Ngā hua rapu - Scott R. Plotkin

Whakamahine hua
  1. 1
    Therapeutic advances for the tumors associated with neurofibromatosis type 1, type 2, and schwannomatosis

    Therapeutic advances for the tumors associated with neurofibromatosis type 1, type 2, and schwannomatosis mā Jaishri O. Blakeley, Scott R. Plotkin

    I whakaputaina 2016
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Increased Risk of Cerebrovascular Disease Among Patients With Neurofibromatosis Type 1

    Increased Risk of Cerebrovascular Disease Among Patients With Neurofibromatosis Type 1 mā Anna R. Terry, Justin T. Jordan, Lee H. Schwamm, Scott R. Plotkin

    I whakaputaina 2015
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    Quality of life among adult patients with neurofibromatosis 1, neurofibromatosis 2 and schwannomatosis: a systematic review of the literature

    Quality of life among adult patients with neurofibromatosis 1, neurofibromatosis 2 and schwannomatosis: a systematic review of the literature mā Ana-Maria Vranceanu, Vanessa L. Merker, Elyse R. Park, Scott R. Plotkin

    I whakaputaina 2013
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    Exacerbation of Cerebral Radiation Necrosis by Bevacizumab

    Exacerbation of Cerebral Radiation Necrosis by Bevacizumab mā Deva S. Jeyaretna, William T. Curry, Tracy T. Batchelor, Anat Stemmer‐Rachamimov, Scott R. Plotkin

    I whakaputaina 2010
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    Glioblastoma care in the elderly

    Glioblastoma care in the elderly mā Justin T. Jordan, Elizabeth R. Gerstner, Tracy T. Batchelor, Daniel P. Cahill, Scott R. Plotkin

    I whakaputaina 2015
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  6. 6
    Natural History of Vestibular Schwannoma Growth and Hearing Decline in Newly Diagnosed Neurofibromatosis Type 2 Patients

    Natural History of Vestibular Schwannoma Growth and Hearing Decline in Newly Diagnosed Neurofibromatosis Type 2 Patients mā Scott R. Plotkin, Vanessa L. Merker, Alona Muzikansky, Fred G. Barker, William H. Slattery

    I whakaputaina 2013
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  7. 7
    Clinical Features of Schwannomatosis: A Retrospective Analysis of 87 Patients

    Clinical Features of Schwannomatosis: A Retrospective Analysis of 87 Patients mā Vanessa L. Merker, Sonia Esparza, Miriam J. Smith, Anat Stemmer‐Rachamimov, Scott R. Plotkin

    I whakaputaina 2012
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  8. 8
    Outcomes of hospitalization in pregnant women with CNS neoplasms: a population-based study

    Outcomes of hospitalization in pregnant women with CNS neoplasms: a population-based study mā Anna R. Terry, Fred G. Barker, Lisa Leffert, Brian T. Bateman, Irene Souter, Scott R. Plotkin

    I whakaputaina 2012
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  9. 9
    Erlotinib for Progressive Vestibular Schwannoma in Neurofibromatosis 2 Patients

    Erlotinib for Progressive Vestibular Schwannoma in Neurofibromatosis 2 Patients mā Scott R. Plotkin, Chris Halpin, Michael J. McKenna, Jay S. Loeffler, Tracy T. Batchelor, Fred G. Barker

    I whakaputaina 2010
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  10. 10
    Expression of SMARCB1 (INI1) mutations in familial schwannomatosis

    Expression of SMARCB1 (INI1) mutations in familial schwannomatosis mā Miriam J. Smith, James A. Walker, Yiping Shen, Anat Stemmer‐Rachamimov, James F. Gusella, Scott R. Plotkin

    I whakaputaina 2012
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  11. 11
    Emotional functioning of patients with neurofibromatosis tumor suppressor syndrome

    Emotional functioning of patients with neurofibromatosis tumor suppressor syndrome mā Daphne L. Wang, Kelly B. Smith, Sonia Esparza, Fawn A. Leigh, Alona Muzikansky, Elyse R. Park, Scott R. Plotkin

    I whakaputaina 2012
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  12. 12
    Bevacizumab for Progressive Vestibular Schwannoma in Neurofibromatosis Type 2

    Bevacizumab for Progressive Vestibular Schwannoma in Neurofibromatosis Type 2 mā Scott R. Plotkin, Vanessa L. Merker, Chris Halpin, Dominique Jennings, Michael J. McKenna, Gordon J. Harris, Fred G. Barker

    I whakaputaina 2012
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  13. 13
    Bevacizumab treatment for symptomatic spinal ependymomas in neurofibromatosis type 2

    Bevacizumab treatment for symptomatic spinal ependymomas in neurofibromatosis type 2 mā Said Farschtschi, Vanessa L. Merker, David S. Wolf, Martin U. Schuhmann, Jaishri O. Blakeley, Scott R. Plotkin, Christian Hagel, Victor F. Mautner

    I whakaputaina 2015
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  14. 14
    NF2/Merlin Is a Novel Negative Regulator of mTOR Complex 1, and Activation of mTORC1 Is Associated with Meningioma and Schwannoma Growth

    NF2/Merlin Is a Novel Negative Regulator of mTOR Complex 1, and Activation of mTORC1 Is Associated with Meningioma and Schwannoma Growth mā Marianne F. James, Sangyeul Han, Carolyn Polizzano, Scott R. Plotkin, Brendan D. Manning, Anat Stemmer‐Rachamimov, James F. Gusella, Vijaya Ramesh

    I whakaputaina 2009
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  15. 15
    Achieving consensus for clinical trials

    Achieving consensus for clinical trials mā Scott R. Plotkin, Jaishri O. Blakeley, Eva Dombi, Michael J. Fisher, C. Oliver Hanemann, Karin S. Walsh, Pamela L. Wolters, Brigitte C. Widemann

    I whakaputaina 2013
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  16. 16
    Treatment of Relapsed Central Nervous System Lymphoma with High-Dose Methotrexate

    Treatment of Relapsed Central Nervous System Lymphoma with High-Dose Methotrexate mā Scott R. Plotkin, Rebecca A. Betensky, Fred H. Hochberg, Stuart A. Grossman, Glenn J. Lesser, Burt Nabors, Brian H. Chon, Tracy T. Batchelor

    I whakaputaina 2004
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  17. 17
    Anti–Vascular Endothelial Growth Factor Therapies as a Novel Therapeutic Approach to Treating Neurofibromatosis-Related Tumors

    Anti–Vascular Endothelial Growth Factor Therapies as a Novel Therapeutic Approach to Treating Neurofibromatosis-Related Tumors mā Hon Kit Wong, Johanna Lahdenranta, Walid S. Kamoun, Annie W. Chan, Andrea I. McClatchey, Scott R. Plotkin, Rakesh K. Jain, Emmanuelle di Tomaso

    I whakaputaina 2010
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  18. 18
    Relationship between whole‐body tumor burden, clinical phenotype, and quality of life in patients with neurofibromatosis

    Relationship between whole‐body tumor burden, clinical phenotype, and quality of life in patients with neurofibromatosis mā Vanessa L. Merker, Miriam A. Bredella, Wenli Cai, Ara Kassarjian, Gordon J. Harris, Alona Muzikansky, Rosa Nguyen, Victor F. Mautner, Scott R. Plotkin

    I whakaputaina 2014
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  19. 19
    Self-reported access to specialty clinics and receipt of health surveillance among U.S. patients with neurofibromatosis 1: a national survey

    Self-reported access to specialty clinics and receipt of health surveillance among U.S. patients with neurofibromatosis 1: a national survey mā Vanessa L. Merker, Yidan Ma, Lori B. Chibnik, Heather B. Radtke, Kate Kelts, Kaleb Yohay, Nicole J. Ullrich, Scott R. Plotkin, Justin T. Jordan

    I whakaputaina 2025
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  20. 20
    Use of Video to Facilitate End-of-Life Discussions With Patients With Cancer: A Randomized Controlled Trial

    Use of Video to Facilitate End-of-Life Discussions With Patients With Cancer: A Randomized Controlled Trial mā Areej El‐Jawahri, Lisa Podgurski, April F. Eichler, Scott R. Plotkin, Jennifer S. Temel, Susan L. Mitchell, Yuchiao Chang, Michael J. Barry, Angelo E. Volandes

    I whakaputaina 2009
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: